TeraWulf
WULF
Cipher Mining
CIFR
BTCS Inc
BTCS
Riot Platforms
RIOT
IREN Ltd
IREN
US Stock MarketDetailed Quotes
ESPR Esperion Therapeutics
- 2.160
- +0.080+3.85%
Trading Jan 24 10:33 ET
425.60MMarket Cap-3.22P/E (TTM)
2.230High2.050Low1.94MVolume2.060Open2.080Pre Close4.22MTurnover0.99%Turnover RatioLossP/E (Static)197.04MShares3.94052wk High-1.15P/B422.40MFloat Cap1.58052wk Low--Dividend TTM195.56MShs Float120.960Historical High--Div YieldTTM8.65%Amplitude0.700Historical Low2.175Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Esperion Therapeutics Stock Forum
Esperion Therapeutics (ESPR), currently priced around $2 per share, is gaining significant attention from analysts, with three experts placing strong BUY ratings on the stock and price targets ranging from $7 to $16. The company, known for ...
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
No comment yet